Quarterly Results

  • Company Name :
Aurobindo Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 524804
  • NSE Symbol:
  • AUROPHARMA
  • P/E(TTM):
  • 36.89
  • ISIN Demat:
  • INE406A01037
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 29.81
  • Book Value(₹):
  • 350.46
  • Market Cap(₹Cr.):
  • 64,438.60
  • Face Value(₹):
  • 1.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 2,721.43 2,883.56 2,757.88
Excise Duty 0.00 0.00 0.00
Net Sales 2,721.43 2,883.56 2,757.88
Other Operating Income 10.56 33.07 66.71
Other Income 113.98 54.26 122.66
Total Income 2,845.97 2,970.89 2,947.25
Total Expenditure 2,135.48 2,203.48 2,103.71
PBIDT 710.49 767.41 843.54
Interest 61.09 66.19 51.63
PBDT 649.40 701.22 791.91
Depreciation 93.88 68.28 68.16
Tax 155.25 164.03 188.43
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -7.90 -3.14 -2.21
Reported Profit After Tax 408.17 472.05 537.53
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 408.17 472.05 537.53
EPS (Unit Curr.) 7.03 8.13 9.21
EPS (Adj) (Unit Curr.) 7.03 8.13 9.21
Calculated EPS (Unit Curr.) 7.03 8.13 9.25
Calculated EPS (Adj) (Unit Curr.) 7.03 8.13 9.25
Calculated EPS (Ann.) (Unit Curr.) 28.11 32.51 37.02
Calculated EPS (Adj) (Ann.) (Unit Curr.) 28.11 32.51 37.02
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 58.08 58.08 58.08
Reserve & Surplus 0.00 0.00 19,598.16
Face Value 1.00 1.00 1.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 26.11 26.61 30.59
PBDTM(%) 23.86 24.32 28.71
PATM(%) 15.00 16.37 19.49